Variant report

Variant	nsv579526
Chromosome Location	chr19:41349732-41384578
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:373)
CpG islands
(count:366)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:373 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41378197-41378436	K562	blood:	n/a	n/a
2	ARID3A	chr19:41370633-41370945	K562	blood:	n/a	n/a
3	ATF1	chr19:41370536-41370948	K562	blood:	n/a	n/a
4	ATF1	chr19:41378237-41378485	K562	blood:	n/a	n/a
5	ATF3	chr19:41378141-41378430	K562	blood:	n/a	n/a
6	ATF3	chr19:41370620-41370877	K562	blood:	n/a	n/a
7	CBX3	chr19:41381255-41381833	K562	blood:	n/a	n/a
8	CBX3	chr19:41370123-41371107	K562	blood:	n/a	n/a
9	CBX3	chr19:41349182-41350047	K562	blood:	n/a	n/a
10	CBX3	chr19:41379769-41380227	K562	blood:	n/a	n/a
11	CBX3	chr19:41379821-41380148	K562	blood:	n/a	n/a
12	CCNT2	chr19:41370582-41370786	K562	blood:	n/a	n/a
13	CEBPB	chr19:41368480-41368982	A549	lung:	n/a	n/a
14	CEBPB	chr19:41378202-41378474	K562	blood:	n/a	n/a
15	CEBPB	chr19:41368761-41369068	Hela-S3	cervix:	n/a	n/a
16	CEBPB	chr19:41367289-41367476	A549	lung:	n/a	n/a
17	CEBPB	chr19:41373920-41374208	K562	blood:	n/a	n/a
18	CEBPB	chr19:41374056-41374100	A549	lung:	n/a	n/a
19	CEBPB	chr19:41378139-41378466	K562	blood:	n/a	n/a
20	CEBPB	chr19:41362024-41362201	K562	blood:	n/a	n/a
21	CEBPB	chr19:41373834-41374300	A549	lung:	n/a	n/a
22	CEBPB	chr19:41370305-41370801	K562	blood:	n/a	chr19:41370433-41370441
23	CEBPB	chr19:41370209-41371189	K562	blood:	n/a	chr19:41370433-41370441
24	CEBPB	chr19:41368416-41368601	K562	blood:	n/a	n/a
25	CEBPB	chr19:41370543-41370910	K562	blood:	n/a	n/a
26	CEBPD	chr19:41370661-41370862	K562	blood:	n/a	n/a
27	CEBPD	chr19:41370295-41371143	K562	blood:	n/a	n/a
28	CTCF	chr19:41354345-41354814	H1-hESC	embryonic stem cell:	n/a	chr19:41354699-41354709
29	CTCF	chr19:41354520-41354670	BJ	skin:	n/a	n/a
30	CTCF	chr19:41364190-41364227	MCF-7	breast:	n/a	n/a
31	CTCF	chr19:41354460-41354610	AG10803	skin:	n/a	n/a
32	CTCF	chr19:41368360-41368510	AG10803	skin:	n/a	n/a
33	CTCF	chr19:41354549-41354665	K562	blood:	n/a	n/a
34	CTCF	chr19:41368540-41368690	AoAF	blood vessel:	n/a	n/a
35	CTCF	chr19:41354500-41354650	AG04449	skin:	n/a	n/a
36	CTCF	chr19:41354460-41354610	HRE	kidney:	n/a	n/a
37	CTCF	chr19:41354459-41354759	K562	blood:	n/a	chr19:41354699-41354709
38	CTCF	chr19:41359824-41359874	LNCaP	prostate:	n/a	n/a
39	CTCF	chr19:41368300-41368450	MCF-7	breast:	n/a	n/a
40	CTCF	chr19:41354520-41354670	HPAF	blood vessel:	n/a	n/a
41	CTCF	chr19:41368380-41368530	A549	lung:	n/a	n/a
42	CTCF	chr19:41381740-41381820	GM13976	blood:	n/a	n/a
43	CTCF	chr19:41354520-41354670	HUVEC	blood vessel:	n/a	n/a
44	CTCF	chr19:41368340-41368490	HPAF	blood vessel:	n/a	n/a
45	CTCF	chr19:41368380-41368530	HPAF	blood vessel:	n/a	n/a
46	CTCF	chr19:41354520-41354670	SAEC	small airway:	n/a	n/a
47	CTCF	chr19:41354333-41354798	H1-hESC	embryonic stem cell:	n/a	chr19:41354699-41354709
48	CTCF	chr19:41354312-41354785	K562	blood:	n/a	chr19:41354699-41354709
49	CTCF	chr19:41354480-41354630	HFF	foreskin:	n/a	n/a
50	CTCF	chr19:41368320-41368470	HVMF	connective:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41351924-41351974	SK-N-SH_RA	brain:	n/a
2	chr19:41383654-41383704	AG10803	skin:	n/a
3	chr19:41383654-41383704	AG04449	skin:	fetal
4	chr19:41354142-41354192	HL-60	blood:	n/a
5	chr19:41354553-41354603	Hela-S3	cervix:	n/a
6	chr19:41354553-41354603	HCT-116	colon:	n/a
7	chr19:41355973-41356023	HIPEpiC	eye:	n/a
8	chr19:41354682-41354732	ECC-1	luminal epithelium:	n/a
9	chr19:41354142-41354192	BE2_C	brain:	n/a
10	chr19:41351924-41351974	HCF	heart:	n/a
11	chr19:41383654-41383704	BJ	skin:	n/a
12	chr19:41355973-41356023	SK-N-SH	brain:	n/a
13	chr19:41355973-41356023	NHDF-neo	bronchial:	n/a
14	chr19:41354142-41354192	U87	brain:	n/a
15	chr19:41351924-41351974	T-47D	breast:	n/a
16	chr19:41355973-41356023	NH-A	brain:	n/a
17	chr19:41354682-41354732	Hepatocyte	liver:	n/a
18	chr19:41354142-41354192	HUVEC	blood vessel:	n/a
19	chr19:41383654-41383704	A549	lung:	n/a
20	chr19:41351924-41351974	HepG2	liver:	n/a
21	chr19:41354553-41354603	AG04449	skin:	fetal
22	chr19:41383654-41383704	U87	brain:	n/a
23	chr19:41354142-41354192	HIPEpiC	eye:	n/a
24	chr19:41354142-41354192	ovcar-3	ovarian:	n/a
25	chr19:41355973-41356023	GM06990	blood:	n/a
26	chr19:41355973-41356023	HEK293	kidney:	embryo
27	chr19:41355973-41356023	SKMC	muscle:	n/a
28	chr19:41354682-41354732	SK-N-SH_RA	brain:	n/a
29	chr19:41351924-41351974	NT2-D1	testis:	n/a
30	chr19:41351924-41351974	NB4	blood:	n/a
31	chr19:41354682-41354732	K562	blood:	n/a
32	chr19:41355973-41356023	Jurkat	blood:	n/a
33	chr19:41354682-41354732	SAEC	small airway:	n/a
34	chr19:41354142-41354192	PFSK-1	brain:	n/a
35	chr19:41355973-41356023	PFSK-1	brain:	n/a
36	chr19:41354142-41354192	T-47D	breast:	n/a
37	chr19:41351924-41351974	Caco-2	colon:	n/a
38	chr19:41354142-41354192	HAEpiC	amniotic membrane:	n/a
39	chr19:41354553-41354603	ovcar-3	ovarian:	n/a
40	chr19:41351924-41351974	HCM	heart:	n/a
41	chr19:41354682-41354732	HPAEpiC	pulmonary alveolar:	n/a
42	chr19:41383654-41383704	CMK	blood:	n/a
43	chr19:41354142-41354192	HEK293	kidney:	embryo
44	chr19:41354682-41354732	NHBE	bronchial:	n/a
45	chr19:41355973-41356023	HCT-116	colon:	n/a
46	chr19:41383654-41383704	AoSMC	blood vessel:	n/a
47	chr19:41354553-41354603	PANC-1	pancreas:	n/a
48	chr19:41354553-41354603	HAEpiC	amniotic membrane:	n/a
49	chr19:41383654-41383704	AG09309	skin:	n/a
50	chr19:41351924-41351974	AG10803	skin:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:4474827..4477394-chr19:41351022..41353007,2	MCF-7	breast:
2	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:
3	chr19:41195484..41197379-chr19:41368669..41371255,2	K562	blood:
4	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:

No data

Variant related genes	Relation type
CYP2A6	TF binding region
CYP2A7	TF binding region
CYP2A6	CpG island
CYP2A7	CpG island
ENSG00000262246	chromatin interactions
ENSG00000103423	chromatin interactions
ENSG00000105245	chromatin interactions

Extended variants
information (count: 1846 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:1846 , 50 per page) page: 1 2 3 4 5 6 7 ... 37

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs28399468	chr19:41349732-41349733	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs72549450	chr19:41349746-41349747	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs5031017	chr19:41349750-41349751	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs6413474	chr19:41349759-41349760	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs561053481	chr19:41349763-41349764	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs529455023	chr19:41349773-41349774	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs5031016	chr19:41349774-41349775	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs550797906	chr19:41349776-41349777	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs370375659	chr19:41349778-41349779	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs145014075	chr19:41349786-41349787	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs569294454	chr19:41349812-41349813	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs201305272	chr19:41349820-41349821	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs199775494	chr19:41349821-41349822	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs149081295	chr19:41349852-41349853	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs200903422	chr19:41349865-41349866	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs539466327	chr19:41349866-41349867	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs143731390	chr19:41349874-41349875	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs551723740	chr19:41349888-41349889	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs374020060	chr19:41349908-41349909	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs370819234	chr19:41349942-41349943	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs373949046	chr19:41349943-41349944	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs555584221	chr19:41349947-41349948	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs573895636	chr19:41349970-41349971	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs2431413	chr19:41349978-41349979	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs527665782	chr19:41349998-41349999	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs577637465	chr19:41350004-41350005	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs544703198	chr19:41350034-41350035	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs2431414	chr19:41350039-41350040	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs72547581	chr19:41350050-41350051	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs560172971	chr19:41350056-41350057	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs572409121	chr19:41350086-41350087	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs542939658	chr19:41350098-41350099	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs570351602	chr19:41350114-41350115	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs561117972	chr19:41350173-41350174	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs531467589	chr19:41350189-41350190	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs531414040	chr19:41350191-41350192	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs549914213	chr19:41350211-41350212	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs145026630	chr19:41350217-41350218	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs386809287	chr19:41350232-41350233	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs2644908	chr19:41350241-41350242	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs533443716	chr19:41350272-41350273	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs551519233	chr19:41350284-41350285	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs566521623	chr19:41350349-41350350	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs549865604	chr19:41350361-41350362	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs60708866	chr19:41350383-41350384	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs534270874	chr19:41350439-41350440	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs186833314	chr19:41350448-41350449	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs567580611	chr19:41350460-41350461	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs72549446	chr19:41350475-41350476	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs2002975	chr19:41350489-41350490	Weak transcription Enhancers Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:338 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41347800-41349800	Weak transcription	Lung	lung
2	chr19:41349200-41349800	Active TSS	Breast Myoepithelial Primary Cells	Breast
3	chr19:41349200-41349800	Enhancers	Primary hematopoietic stem cells short term culture	blood
4	chr19:41349200-41349800	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
5	chr19:41349200-41349800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
6	chr19:41349200-41350000	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
7	chr19:41349200-41350000	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
8	chr19:41349200-41350200	Active TSS	HUES64 Cell Line	embryonic stem cell
9	chr19:41349200-41350200	Active TSS	Primary B cells from cord blood	blood
10	chr19:41349200-41350200	Enhancers	Primary T cells from cord blood	blood
11	chr19:41349200-41350400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
12	chr19:41349200-41350400	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
13	chr19:41349200-41350800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
14	chr19:41349400-41349800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
15	chr19:41349400-41349800	Active TSS	H9 Cell Line	embryonic stem cell
16	chr19:41349400-41349800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
17	chr19:41349400-41349800	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr19:41349400-41349800	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
19	chr19:41349400-41349800	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
20	chr19:41349400-41349800	Active TSS	Primary mononuclear cells fromperipheralblood	Blood
21	chr19:41349400-41349800	Active TSS	Colonic Mucosa	Colon
22	chr19:41349400-41349800	Flanking Active TSS	Fetal Thymus	thymus
23	chr19:41349400-41349800	Active TSS	Rectal Mucosa Donor 31	rectum
24	chr19:41349400-41349800	Active TSS	Right Ventricle	heart
25	chr19:41349400-41349800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
26	chr19:41349400-41350000	Active TSS	ES-WA7 Cell Line	embryonic stem cell
27	chr19:41349400-41350000	Active TSS	H1 Cell Line	embryonic stem cell
28	chr19:41349400-41350000	Active TSS	HUES48 Cell Line	embryonic stem cell
29	chr19:41349400-41350000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr19:41349400-41350000	Active TSS	Primary T helper naive cells fromperipheralblood	blood
31	chr19:41349400-41350000	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
32	chr19:41349400-41350000	Enhancers	Left Ventricle	heart
33	chr19:41349400-41350000	Active TSS	Pancreas	Pancrea
34	chr19:41349400-41350000	Active TSS	Rectal Mucosa Donor 29	rectum
35	chr19:41349400-41350000	Active TSS	Thymus	Thymus
36	chr19:41349400-41350200	Active TSS	ES-I3 Cell Line	embryonic stem cell
37	chr19:41349400-41350200	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
38	chr19:41349400-41350200	Flanking Active TSS	Primary T cells fromperipheralblood	blood
39	chr19:41349400-41350200	Enhancers	K562	blood
40	chr19:41349400-41350400	Enhancers	Stomach Mucosa	stomach
41	chr19:41349600-41349800	Flanking Bivalent TSS/Enh	IMR90 fetal lung fibroblasts Cell Line	lung
42	chr19:41349600-41349800	Active TSS	Primary T helper 17 cells PMA-I stimulated	--
43	chr19:41349600-41349800	Enhancers	Primary T killer memory cells from peripheral blood	blood
44	chr19:41349600-41349800	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
45	chr19:41349600-41349800	Bivalent/Poised TSS	Foreskin Melanocyte Primary Cells skin03	Skin
46	chr19:41349600-41350000	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
47	chr19:41349600-41350000	Active TSS	iPS-15b Cell Line	embryonic stem cell
48	chr19:41349600-41350000	Active TSS	iPS-20b Cell Line	embryonic stem cell
49	chr19:41349600-41350000	Active TSS	Primary B cells from peripheral blood	blood
50	chr19:41349600-41350000	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links